- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Activation of Natural Killer T Cells by NK-4, a Criptocyanine Dye
-
- KUNIKATA Toshio
- Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc.
-
- KOHNO Keizo
- Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc.
-
- USHIO Shimpei
- Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc.
-
- FUKUDA Shigeharu
- Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc.
Bibliographic Information
- Other Title
-
- クリプトシアニン色素(NK-4)によるNatural Killer T (NKT)細胞活性化作用
- クリプトシアニン シキソ(NK-4)ニ ヨル Natural Killer T (NKT)サイボウ カッセイカ サヨウ
Search this article
Description
We previously reported that oral administration of NK-4, a criptocyanine dye, enhances interleukin (IL)-12-depend- ent interferon (IFN)-γ production by lipopolysaccharide (LPS)-stimulated mouse splenocytes. These findings raised a possibility that NK-4 potentiated IFN-γ production by T cells, natural killer (NK) cells or natural killer T (NKT) cells in response to IL-12 produced by macrophage and dendritic cells. To explore this possibility, we first analyzed percentages of T, NK or NKT cells in splenocytes of mice that were administered NK-4 orally for three days. The percentage of NKT cells in splenocytes from NK-4-treated mice was significantly (p<0.05) increased compared to vehicle-treated mice. When splenocytes were stimulated with α-galactosylceramide (α-GalCer), an NKT cell ligand, IFN-γ production by splenocytes from NK-4-treated mice tended to increase, while no difference in the IL-4 production and proliferation were observed between the vehicle- and NK-4-treated mice. When IFN-γ/IL-4 ratios were calculated in individual mice, the ratios were significantly (p<0.05) elevated in NK-4-treated mice. Furthermore, IL-12 production by α-GalCer-stimulated splenocytes from NK-4-treated mice was also significantly (p<0.05) increased. These results suggest that oral administration of NK-4 increases the population of type I NKT cells with potent IFN-γ-producing activities. Since IL-12 and IFN-γ have been shown to play important roles in anti-tumor immunity as well as in the defence against bacterial infection, our results further imply that NK-4 may provide a potential therapeutic tool in cancer immunotherapy.<br>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 131 (11), 1667-1674, 2011-11-01
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001206128776192
-
- NII Article ID
- 130001491123
-
- NII Book ID
- AN00284903
-
- ISSN
- 13475231
- 00316903
-
- NDL BIB ID
- 023202593
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed